Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Significant Components of Net Deferred Tax Assets (Detail)

v3.23.1
Income Taxes - Schedule of Significant Components of Net Deferred Tax Assets (Detail) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets    
Net operating loss carryforward $ 53,957 $ 63,372
Interest 0 603
Research and development credits 15,235 12,422
Deferred stock compensation 8,086 5,916
Deferred revenue 16,127 699
Lease liability 4,516 3,095
Accrued expenses and other 1,846 1,636
Capitalized Research & Experimental Expenditures 19,764 0
Total deferred tax assets 119,531 87,743
Total deferred tax liabilities    
Depreciable and amortizable assets (1,329) (1,459)
Right-of-use asset (3,488) (2,189)
Total deferred tax liabilities (4,817) (3,648)
Less: Valuation allowance (114,714) (84,095)
Net deferred tax assets $ 0 $ 0